114 related articles for article (PubMed ID: 34707096)
1. Exploration of the shared pathways and common biomarker in adamantinomatous craniopharyngioma and type 2 diabetes using integrated bioinformatics analysis.
Han Y; Wang Y; Li S; Sato K; Yamagishi S
PLoS One; 2024; 19(6):e0304404. PubMed ID: 38848397
[TBL] [Abstract][Full Text] [Related]
2. The molecular pathogenesis of craniopharyngiomas.
Campanini ML; Almeida JP; Martins CS; de Castro M
Arch Endocrinol Metab; 2023 Mar; 67(2):266-275. PubMed ID: 36748936
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysis.
Prince EW; Apps JR; Jeang J; Chee K; Medlin S; Jackson EM; Dudley R; Limbrick D; Naftel R; Johnston J; Feldstein N; Prolo LM; Ginn K; Niazi T; Smith A; Kilburn L; Chern J; Leonard J; Lam S; Hersh DS; Gonzalez-Meljem JM; Amani V; Donson AM; Mitra SS; Bandopadhayay P; Martinez-Barbera JP; Hankinson TC
Neuro Oncol; 2024 Jun; 26(6):1109-1123. PubMed ID: 38334125
[TBL] [Abstract][Full Text] [Related]
4. Biological Behaviour of Craniopharyngiomas.
Martinez-Barbera JP; Andoniadou CL
Neuroendocrinology; 2020; 110(9-10):797-804. PubMed ID: 32126562
[TBL] [Abstract][Full Text] [Related]
5. Multi-omics analysis of adamantinomatous craniopharyngiomas reveals distinct molecular subgroups with prognostic and treatment response significance.
Wang X; Zhao C; Lin J; Liu H; Zeng Q; Chen H; Wang Y; Xu D; Chen W; Xu M; Zhang E; Lin D; Lin Z
Chin Med J (Engl); 2024 Apr; 137(7):859-870. PubMed ID: 37565822
[TBL] [Abstract][Full Text] [Related]
6. Multiomics integration-based immunological characterizations of adamantinomatous craniopharyngioma in relation to keratinization.
Xu C; Wu J; Ye J; Si Y; Zhang J; Wu B; Pan L; Fu J; Ren Q; Xie S; Tang B; Xiao Y; Hong T
Cell Death Dis; 2024 Jun; 15(6):439. PubMed ID: 38906852
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma.
Andoniadou CL; Gaston-Massuet C; Reddy R; Schneider RP; Blasco MA; Le Tissier P; Jacques TS; Pevny LH; Dattani MT; Martinez-Barbera JP
Acta Neuropathol; 2012 Aug; 124(2):259-71. PubMed ID: 22349813
[TBL] [Abstract][Full Text] [Related]
8. Proteomics study of primary and recurrent adamantinomatous craniopharyngiomas.
Deng H; Lei T; Liu S; Hao W; Hu M; Xiang X; Ye L; Chen D; Li Y; Liu F
Clin Proteomics; 2024 Apr; 21(1):29. PubMed ID: 38594611
[TBL] [Abstract][Full Text] [Related]
9. Comparison of central diabetes insipidus (antidiuretic hormone deficiency) and stalk effect in patients with adamantinomatous and papillary craniopharyngioma.
Feng Y; Zhong L
Acta Neurol Belg; 2024 Apr; ():. PubMed ID: 38669000
[TBL] [Abstract][Full Text] [Related]
10. Analysis of KLRB1-mediated immunosuppressive regulation in adamantinomatous craniopharyngioma.
Wei W
J Neurol Surg A Cent Eur Neurosurg; 2024 Apr; ():. PubMed ID: 38657676
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of integrated stress response protects against lipid-induced senescence in hypothalamic neural stem cells in adamantinomatous craniopharyngioma.
Wang C; Zhang H; Fan J; Li Q; Guo R; Pan J; Liu Y; Peng J; Zhu Q; Feng Y; Wu C; Luo P; Qiu X; Shi J; Deng Y; Qi S; Liu Y
Neuro Oncol; 2023 Apr; 25(4):720-732. PubMed ID: 36454228
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic control of adamantinomatous craniopharyngiomas.
Marrero-Gutiérrez J; Bueno AC; Martins CS; Coeli-Lacchini FB; Silva-Júnior RMP; Marques Gonçalves GH; Ozaki JGO; de Almeida E Silva DC; Wildemberg LE; da Silva Antunes XL; Dos Santos AC; Machado HR; Santos MV; Moreira AC; Gadelha MR; Vêncio RZN; Antonini SRR; de Castro M
J Clin Endocrinol Metab; 2024 Jan; ():. PubMed ID: 38181427
[TBL] [Abstract][Full Text] [Related]
13. Management of Childhood-onset Craniopharyngioma in Italy: A Multicenter, 7-Year Follow-up Study of 145 Patients.
Zucchini S; Di Iorgi N; Pozzobon G; Pedicelli S; Parpagnoli M; Driul D; Matarazzo P; Baronio F; Crocco M; Iudica G; Partenope C; Nardini B; Ubertini G; Menardi R; Guzzetti C; Iughetti L; Aversa T; Di Mase R; Cassio A;
J Clin Endocrinol Metab; 2022 Feb; 107(3):e1020-e1031. PubMed ID: 34718649
[TBL] [Abstract][Full Text] [Related]
14. Protein Signatures of Parathyroid Adenoma according to Tumor Volume and Functionality.
Kong SH; Bae JM; Kim JH; Kim SW; Han D; Shin CS
Endocrinol Metab (Seoul); 2024 Apr; 39(2):375-386. PubMed ID: 38509667
[TBL] [Abstract][Full Text] [Related]
15. MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas.
Sigaud R; Albert TK; Hess C; Hielscher T; Winkler N; Kocher D; Walter C; Münter D; Selt F; Usta D; Ecker J; Brentrup A; Hasselblatt M; Thomas C; Varghese J; Capper D; Thomale UW; Hernáiz Driever P; Simon M; Horn S; Herz NA; Koch A; Sahm F; Hamelmann S; Faria-Andrade A; Jabado N; Schuhmann MU; Schouten-van Meeteren AYN; Hoving E; Brummer T; van Tilburg CM; Pfister SM; Witt O; Jones DTW; Kerl K; Milde T
Nat Commun; 2023 Jul; 14(1):4533. PubMed ID: 37500667
[TBL] [Abstract][Full Text] [Related]
16. BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience.
Trinder SM; McKay C; Power P; Topp M; Chan B; Valvi S; McCowage G; Govender D; Kirby M; Ziegler DS; Manoharan N; Hassall T; Kellie S; Heath J; Alvaro F; Wood P; Laughton S; Tsui K; Dodgshun A; Eisenstat DD; Endersby R; Luen SJ; Koh ES; Sim HW; Kong B; Gottardo NG; Whittle JR; Khuong-Quang DA; Hansford JR
Front Oncol; 2023; 13():1154246. PubMed ID: 37124503
[TBL] [Abstract][Full Text] [Related]
17. One-Week Dynamic Changes in Cardiac Proteomes After Cardiac Radioablation in Experimental Rat Model.
Kim BH; Jung JW; Han D; Cha MJ; Chang JH
Front Cardiovasc Med; 2022; 9():898222. PubMed ID: 35837601
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Proteins Responsible for Resistance to Three Chemotherapy Drugs in Breast Cancer Cells Using Proteomics and Bioinformatics Analysis.
Cha HK; Cheon S; Kim H; Lee KM; Ryu HS; Han D
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335125
[TBL] [Abstract][Full Text] [Related]
19. In-depth proteomic profiling captures subtype-specific features of craniopharyngiomas.
Kim JH; Kim H; Dan K; Kim SI; Park SH; Han D; Kim YH
Sci Rep; 2021 Oct; 11(1):21206. PubMed ID: 34707096
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
